Dried blood spot as an alternative sample for screening of fatty acid, amino acid, and keto acid metabolism in humans.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5431
- By:
- Publication type:
- Article
Works matching IS 02693879 AND DT 2022 AND VI 36 AND IP 9
Results: 21
1
2
Tracing analgesic constituents from crude and vinegar‐processed resin of Boswellia carterii by integrating ultra‐performance liquid chromatography tandem mass spectrometry–based determination, analgesic evaluation in mice, and gray relationship analysis
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5430
- By:
- Publication type:
- Article
3
Stability‐indicating HPLC method development and validation of rivaroxaban impurities and identification of forced degradation products using LC–MS/MS.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5424
- By:
- Publication type:
- Article
4
Targeted profiling of rodent unconjugated bile acids using GC–MS to determine the influence of high‐fat diet.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5428
- By:
- Publication type:
- Article
5
In‐depth investigation of the Silymarin effect on the pharmacokinetic parameters of sofosbuvir, GS‐331007 and ledipasvir in rat plasma using LC–MS.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5427
- By:
- Publication type:
- Article
6
Screening 5‐lipoxygenase inhibitors from selected traditional Chinese medicines and isolation of the active compounds from Polygoni Cuspidati Rhizoma by an on‐line bioactivity evaluation system.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5426
- By:
- Publication type:
- Article
7
Effect of concomitant oral administration of ethanol on the pharmacokinetics of nicardipine in rats.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5425
- By:
- Publication type:
- Article
8
Inhibition of α‐glucosidase by Cyclocarya paliurus based on HPLC fingerprinting integrated with molecular docking and molecular dynamics.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5429
- By:
- Publication type:
- Article
9
Quantitative determination of LY‐404,039, a metabotropic glutamate 2/3 receptor agonist, in rat plasma using chemical derivatization and HPLC–MRM/MS.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5423
- By:
- Publication type:
- Article
10
Exploring the Q‐markers of Angelica sinensis (Oliv.) Diels of anti‐platelet aggregation activity based on spectrum–effect relationships.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5422
- By:
- Publication type:
- Article
11
An observation study of urinary biomarker exploratory in Alzheimer's disease using high‐resolution mass spectrometry.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5421
- By:
- Publication type:
- Article
12
High‐throughput UPLC‐Q‐TOF‐MS/MS coupled with multivariable data processing approach for the rapid screening and characterization of chemical constituents and potential bioactive compounds from Danggui Shaoyao San.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5420
- By:
- Publication type:
- Article
13
Determination of isoscoparin in mouse blood using UPLC–MS/MS and its pharmacokinetics.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5419
- By:
- Publication type:
- Article
14
Residue levels, household processing evolution, and risk assessment of chlorothalonil, SDS‐3701, metalaxyl, and dimethomorph in Dendrobium officinale Kimura et Migo.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5418
- By:
- Publication type:
- Article
15
Investigation of the apoptosis‐inducing effect of docetaxel by comprehensive LC–MS–based metabolomics and network pharmacology approaches.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5417
- By:
- Publication type:
- Article
16
Hybrid solid‐phase extraction to overcome interference due to phospholipids for determination of neratinib in human plasma using UPLC–MS/MS.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5416
- By:
- Publication type:
- Article
17
UHPLC–MS/MS method for the determination of azithromycin in human plasma of pediatric patients.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5415
- By:
- Publication type:
- Article
18
Proteomics analyses of Xiaopi granules in N‐methyl‐N′‐nitro‐N‐nitrosoguanidine–induced gastric epithelial dysplasia rat model using LC–MS.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5414
- By:
- Publication type:
- Article
19
In silico–in vitro estimation of lipophilicity and permeability association for succinimide derivatives using chromatographic anisotropic systems and parallel artificial membrane permeability assay.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5413
- By:
- Publication type:
- Article
20
Fully validated UPLC–MS/MS method for quantifying Favipiravir in human plasma boosted lean six sigma: An application for a bioequivalence study.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5381
- By:
- Publication type:
- Article
21
Issue Information.
- Published in:
- Biomedical Chromatography, 2022, v. 36, n. 9, p. 1, doi. 10.1002/bmc.5165
- Publication type:
- Article